---
title: "Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293049677.md"
description: "Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027"
datetime: "2026-07-17T14:15:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293049677.md)
  - [en](https://longbridge.com/en/news/293049677.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293049677.md)
generator: "portal-rs"
---

# Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027


### Related Stocks

- [URGN.US](https://longbridge.com/en/quote/URGN.US.md)

## Related News & Research

- [Urogen Pharma $URGN Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC](https://longbridge.com/en/news/298881923.md)
- [UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million](https://longbridge.com/en/news/296828951.md)
- [4,000 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by JW Asset Management LLC](https://longbridge.com/en/news/298374596.md)
- [Why is CooperCompanies stock down 15% today?](https://longbridge.com/en/news/298636554.md)
- [Dr. Reddy’s Issues New ESOP Shares After ADR Option Exercise](https://longbridge.com/en/news/298620436.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**